Qube Research & Technologies (QRT)
ANIP icon

Qube Research & Technologies (QRT)’s ANI Pharmaceuticals ANIP Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16M Sell
192,945
-17,185
-8% -$1.38M 0.01% 1021
2026
Q1 		$16.2M Sell
210,130
-7,751
-4% -$605K 0.02% 1004
2025
Q4 		$17.2M Buy
217,881
+27,680
+15% +$2.4M 0.02% 995
2025
Q3 		$17.4M Buy
190,201
+114,016
+150% +$9.3M 0.02% 963
2025
Q2 		$4.97M Buy
76,185
+40,481
+113% +$2.64M 0.01% 1703
2025
Q1 		$2.39M Sell
35,704
-24,216
-40% -$1.45M ﹤0.01% 1889
2024
Q4 		$3.31M Sell
59,920
-15,785
-21% -$906K ﹤0.01% 1683
2024
Q3 		$4.52M Sell
75,705
-81,290
-52% -$4.96M 0.01% 1438
2024
Q2 		$10M Buy
156,995
+39,469
+34% +$2.56M 0.02% 923
2024
Q1 		$8.12M Buy
117,526
+13,291
+13% +$802K 0.01% 957
2023
Q4 		$5.75M Buy
104,235
+52,440
+101% +$2.89M 0.01% 972
2023
Q3 		$3.01M Buy
+51,795
New +$2.99M 0.01% 1173
2022
Q2 		– Sell
-11,412
Closed -$321K – 2457
2022
Q1 		$321K Buy
+11,412
New +$426K ﹤0.01% 1751

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ANIP Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its ANI Pharmaceuticals (ANIP) stake by 8.2% in Q2 2026, selling an estimated $1.38M and leaving 192,945 shares worth $16M. The position accounts for 0.01% of the portfolio, ranked #1021.

Qube Research & Technologies (QRT) first reported a position in ANIP in Q1 2022 and has held it in 13 quarters since. The position peaked at $17.4M in Q3 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Qube Research & Technologies (QRT) held 192,945 shares of ANI Pharmaceuticals worth $16M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 17,185 ANI Pharmaceuticals shares in Q2 2026, an estimated $1.38M.
  • ANI Pharmaceuticals made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1021 holding.
  • Qube Research & Technologies (QRT) first reported a position in ANI Pharmaceuticals in Q1 2022 and has held it in 13 quarters since.
  • Qube Research & Technologies (QRT)'s ANI Pharmaceuticals position peaked at $17.4M in Q3 2025.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.